Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On January 6, 2026, Genprex, Inc. (“Genprex” or the “Company”) issued a press release announcing positive preliminary preclinical data from the st
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIG